Literature DB >> 8663475

The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor.

K Fukudome1, S Kurosawa, D J Stearns-Kurosawa, X He, A R Rezaie, C T Esmon.   

Abstract

Expression of the endothelial cell protein C receptor (EPCR) gene in mammalian cells imparts the capacity to bind activated protein C (APC) or protein C. Immunochemical analysis of CCD41, apparently the murine homologue of EPCR, suggested centrosomal localization, raising questions about the location of the EPCR gene product and its role in protein C binding. In this study, we express a soluble form of EPCR, demonstrate EPCR expression on the cell surface, and direct binding between soluble EPCR and protein C/APC. Affinity purified polyclonal and a monoclonal antibody against EPCR bound to the cell surface of EPCR-transfected cells but not to control cells. A 49-kDa protein, a mass similar to soluble EPCR, was immunoprecipitated from the cell surface of endothelium and cells transfected with human EPCR but not from control cells. The FLAGtrade mark antibody and APC bound to cells expressing an EPCR construct containing the FLAGtrade mark epitope located in a putative extracellular domain, whereas an EPCR construct truncated just before the putative transmembrane domain produced only soluble EPCR antigen. Soluble EPCR inhibited APC binding to EPCR expressing cells in a concentration-dependent fashion, Kd (app) = 29 nM and bound to immobilized protein C in a Ca2+-dependent fashion. Thus, EPCR is a type 1 transmembrane protein that binds directly to APC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663475     DOI: 10.1074/jbc.271.29.17491

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis.

Authors:  M M Boomsma; D J Stearns-Kurosawa; C A Stegeman; E Raschi; P L Meroni; S Kurosawa; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

3.  Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo.

Authors:  Laura D Healy; Cristina Puy; José A Fernández; Annachiara Mitrugno; Ravi S Keshari; Nyiawung A Taku; Tiffany T Chu; Xiao Xu; András Gruber; Florea Lupu; John H Griffin; Owen J T McCarty
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

4.  Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

Authors:  Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

5.  The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.

Authors:  Giulia Pavani; Lacramioara Ivanciu; Armida Faella; Oscar A Marcos-Contreras; Paris Margaritis
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

6.  Piperlonguminine downregulates endothelial protein C receptor shedding in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

7.  Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Authors:  Qiulan Ding; Likui Yang; Seyed Mahdi Hassanian; A R Rezaie
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

8.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

Authors:  D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.

Authors:  Ram Vinod Roy; Abdolreza Ardeshirylajimi; Peyman Dinarvand; Likui Yang; Alireza R Rezaie
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

10.  Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant.

Authors:  Jens E V Petersen; Eveline A M Bouwens; Ibai Tamayo; Louise Turner; Christian W Wang; Monique Stins; Thor G Theander; José Hermida; Laurent O Mosnier; Thomas Lavstsen
Journal:  Thromb Haemost       Date:  2015-07-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.